-
1Academic Journal
Συγγραφείς: M. E. Aksenova, S. L. Morozov, M. V. Shumikhina, М. Е. Аксенова, С. Л. Морозов, М. В. Шумихина
Πηγή: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 68, № 1 (2023); 128-132 ; Российский вестник перинатологии и педиатрии; Том 68, № 1 (2023); 128-132 ; 2500-2228 ; 1027-4065
Θεματικοί όροι: лучевая терапия, children oncology, cancer treatment, kidney complications, nephrotoxicity, radiotherapy, детская онкология, терапия рака, ренальные осложнения, нефротоксичность
Περιγραφή αρχείου: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/1786/1352; Рыков М.Ю. Общенациональная программа по борьбе с онкологическими заболеваниями: детская онкология. Российский вестник перинатологии и педиатрии. 2018; 63(5): 6–12. DOI:10.21508/1027–4065–2018–63–5–6–12; Рыков М.Ю., Менткевич Г.Л. Гемобластозы у детей: трудности диагностики. Российский вестник перинатологии и педиатрии 2017; 62(6): 81–86. DOI:10.21508/1027–4065–2017–62–6–81–86; Kooijmans E., Bökenkamp A., Tjahjadi N., Tettero J., van Dulmen-den Broeder E., van der Pal H., Veening M. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database of Systematic Reviews 2019; 3(3): CD008944. DOI:10.1002/14651858.CD008944.pub3; Green D., Wang M., Krasin M., Srivastava D., Onder S., Jay D. et al. Kidney Function after Treatment for Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study. JASN 2021; 32(4): 983–993. DOI:10.1681/ASN.2020060849; Skinner R. Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance. Pediatr Nephrol 2018; 33(2): 215–225. DOI:10.1007/s00467–017–3662-z; Sanpakit K., Triwatanawong J., Sumboonnanonda A. Longterm outcome in pediatric renal tumor survivors: experience of a single center. J Pediatr Hematol Oncol 2013; 35(8): 610–613. DOI:10.1097/MPH.0b013e3182a06265; Elzembely M., Dahlberg A., Pinto N., Leger K., Chow E., Park J. et al. Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue. Pediatric Blood Cancer 2018; 66(1): e27421. DOI:10.1002/pbc.27421; Sutton E., Tong R., Gillis A., Henning T., Weinberg V., Boddington S. et al. Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy. Pediatr Radiol 2009; 39(11): 1194–1202. DOI:10.1007/s00247–009–1351–1; Yang E., Marmagkiolis K., Balanescu D., Hakeem A., Donisan T., Finch W. et al. Radiation-Induced Vascular Disease. Frontiers in Cardiovascular Medicine 2021; 30(8): 652761. DOI:10.3389/fcvm.2021.652761; Klaus R., Niyazi M., Lange-Sperandio B. Radiation-induced kidney toxicity: molecular and cellular pathogenesis. Radiat Oncol 2021; 16(1):43. DOI:10.1186/s13014–021–01764-y; Dieffenbach B., Liu Q., Murphy A., Stein D., Wu N., Madenci A. et al. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer 2021; 155: 216–226. DOI:10.1016/j.ejca.2021.06.050; van Kalsbeek R. van der Pal H., Kremer L., Bardi E., Brown M., Effeney R. et al. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer. Eur J Cancer 2021; 154: 316–328. DOI:10.1016/j.ejca.2021.06.004; Nada A., Jetton J. Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant. Pediatr Nephrol 2022; 37(6): 1285–1300. DOI:10.1007/s00467–021–05172-y; Сhildren’s oncology group. https://childrensoncologygroup.org/survivorshipguidelines / Ссылка активна на 31.07.2022; Хижников А.В., Рябов А.Б., Поддубный И.В., Шмыров О.С., Трунов В.О., Пименов Р.И. и др. Лапароскопические резекции почек у детей с нефробластомой (обзор литературы). Детская хирургия. Журнал им. Ю.Ф. Исакова 2022; 26(2): 87–95. DOI:10.55308/1560–9510–2022–26–2–87–95